Concepedia

Jane L. Roberts

JL

Statistics

Publications

54

Citations

2.3K

H-Index

32

Active since

2004

Affiliations

Virginia Commonwealth University(Current)

Puma Biotechnology (United States)

University of Richmond

The University of Texas Health Science Center at Houston

UPMC Hillman Cancer Center

Jane L. Roberts is an author at Virginia Commonwealth University specializing in pharmacology, oncology, and molecular oncology.

Publications per year

2004–2022

54

Publications

54

High-Density Lipoproteins Neutralize C-Reactive Protein Proinflammatory Activity

Carol Wadham, Nathaniel Albanese, Jane L. Roberts et al. · Circulation · 2004 · 160 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

HDAC inhibitors enhance the immunotherapy response of melanoma cells

Laurence Booth, Jane L. Roberts, Andrew Poklepovic et al. · Oncotarget · 2017 · 136 citations · Full text

Medicine, Oncology, Pharmacology +17

GRP78/BiP/HSPA5/Dna K is a universal therapeutic target for human disease

Laurence Booth, Jane L. Roberts, Devin R. Cash et al. · Journal of Cellular Physiology · 2014 · 98 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Neratinib inhibits Hippo/YAP signaling, reduces mutant K-RAS expression, and kills pancreatic and blood cancer cells

Paul Dent, Laurence Booth, Jane L. Roberts et al. · Oncogene · 2019 · 85 citations · Full text

Medicine, Cancer Biology, Oncology +16

Phosphodiesterase 5 Inhibitors Enhance Chemotherapy Killing in Gastrointestinal/Genitourinary Cancer Cells

Laurence Booth, Jane L. Roberts, Nichola Cruickshanks et al. · Molecular Pharmacology · 2013 · 71 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 54